|
|
Addressing Key Questions About BCMA-Targeted Therapy for Relapsed/Refractory Multiple Myeloma
ACTIVITY DESCRIPTION
Though treatment advances have improved outcomes for most patients, MM remains an incurable disease characterized by continuous relapse. However, the treatment landscape for relapsed/refractory MM (RRMM) has expanded in recent years, and patients who relapse and/or become refractory to initial therapies are benefiting from the increasing availability of a diverse range of novel agents, including B-cell maturation antigen (BCMA)"targeted immunotherapies. These agents ... |
|
|
Navigating Novel Terrain in Vitiligo Management: A Practical, Patient-Centric Review
Target Audience
This educational activity is targeted to Advanced Practice Providers (APPs) " Physician Assistants and Nurse Practitioners " who practice in community settings.
Program Overview
This online activity will provide Advanced Practice Providers (APPs) " Physician Assistants and Nurse Practitioners " with a comprehensive overview of vitiligo, emphasizing pathogenic mechanisms, patient burden, and emerging treatment approaches.
Learning Objectives
Upon com... |
|